Evaluation of an Optimal Dose of Low-Molecular-Weight Heparin for Thromboprophylaxis in Pregnant Women at Risk of Thrombosis Using Coagulation Activation Markers

Publisher： Karger

E-ISSN： 1424-8840|31|2|90-98

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.31, Iss.2, 2001-10, pp. : 90-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thromboprophylaxis with Low-Molecular- Weight Heparin: Economic Considerations

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 141-145

Karger

Access to resources Recommend Favorite

The influence of low molecular weight heparin medication on plasma DNA in pregnant women

By  

PRENATAL DIAGNOSIS, Vol. 35, Iss. 11, 2015-11 ,pp. : 1155-1157

John Wiley & Sons Inc

Access to resources Recommend Favorite

LOW‐MOLECULAR‐WEIGHT HEPARIN NOT EFFECTIVE AT PREVENTING PREGNANCY COMPLICATONS IN WOMEN WITH THROMBOPHILIAS

By  

JOURNAL OF MIDWIFERY & WOMEN'S HEALTH, Vol. 60, Iss. 1, 2015-01 ,pp. : 106-106

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combinations of Low Doses of Unfractionated Heparin and of Low-Molecular-Weight Heparin Prevent Experimental Venous Thrombosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 6, 2006-06 ,pp. : 263-268

Karger

Access to resources Recommend Favorite

Thrombogenesis in Thrombophilic Pregnancy: Evaluation of Low-Molecular-Weight Heparin Prophylaxis

By  

Acta Haematologica, Vol. 137, Iss. 4, 2017-05 ,pp. : 201-206

Karger

Access to resources Recommend Favorite